Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Front Pediatr ; 9: 604899, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33718296

RESUMEN

Objective: Necrotizing enterocolitis (NEC) is characterized by peripheral cell abnormalities, yet few studies have analyzed the complete blood count (CBC) specifically by gestational age (GA). Our objective was to describe GA-specific immune abnormalities in NEC through a comprehensive analysis of the CBC differential. Methods: Using a cohort of 246 infants (177 cases, 69 controls) admitted to neonatal intensive care units at a single institution, we retrospectively analyzed CBCs around illness onset in NEC cases compared with controls. Cases included surgical NEC (S-NEC, 34.5%) and medical NEC (M-NEC, 65.5%). Infants were divided into those born at GA <33 and ≥33 weeks. Differences in CBC values were described as absolute and percent changes at NEC onset from baseline and at antibiotic completion after NEC. We used machine learning algorithms based on the CBC at NEC to generate predictive models for diagnosis. Results: At NEC onset, there was an acute drop in monocytes and lymphocytes along with a rise in bands in S-NEC infants born <33 weeks compared with M-NEC. In comparison, both M-NEC and S-NEC ≥33 weeks had a percent drop in neutrophils at diagnosis compared with controls. At antibiotic completion, monocytes in S-NEC <33 weeks significantly rose compared with M-NEC, yet for S-NEC ≥33 weeks, bands significantly dropped compared with M-NEC. Predictive modeling was able to accurately predict S-NEC from M-NEC and controls. Conclusion: There are discrete leukocyte patterns in NEC based on GA. The CBC at diagnosis may be useful in identifying patients who will require surgery.

2.
Pediatr Dev Pathol ; 20(6): 498-505, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28403691

RESUMEN

Autoinflammatory diseases are caused by pathologic activation of the innate immune system. Primary hemophagocytic lymphohistiocytosis (HLH) is an aggressive syndrome of excessive immune activation caused by monogenic mutations resulting in cytotoxic cell defects and subsequent failure to eliminate activated macrophages. Secondary HLH is often diagnosed in cases without a known Mendelian inheritance. However, some cases of "secondary" HLH have been shown to harbor mutations with partial dysfunction of the cytotoxic system. Recently, macrophage intrinsic abnormalities caused by NLRC4 inflammasome mutations have been linked to autoinflammation and recurrent macrophage activation syndromes resembling a primary HLH. We report a case of a former 28-week preterm infant with congenital anemia, ascites, and a heavy edematous placenta with fetal thrombotic vasculopathy, who developed hepatosplenomegaly and unexplained systemic inflammation with laboratory features of HLH in the early postnatal course and died at 2 months of age. Postmortem examination confirmed the hepatosplenomegaly with marked sinusoidal hemophagocytosis, along with striking hemophagocytosis in the bone marrow and lymph nodes. There was extensive acute and chronic ischemic bowel disease with matted bowel loops, fibrous adhesions, and patchy necrotizing enterocolitis features. Whole exome sequencing analysis demonstrated a novel mosaic heterozygous NLRC4 512 C> T (p.Ser171Phe) de novo mutation predicated to cause a dominant, gain-of-function mutation resulting in a constitutively active protein. The assembly of NLRC4-containing inflammasomes via an induced self-propagation mechanism likely enables a perpetuating process of systemic macrophage activation, presumed to be initiated in utero in this patient.


Asunto(s)
Proteínas Adaptadoras de Señalización CARD/genética , Proteínas de Unión al Calcio/genética , Mutación con Ganancia de Función , Hepatomegalia/genética , Enfermedades Autoinflamatorias Hereditarias/genética , Linfohistiocitosis Hemofagocítica/genética , Esplenomegalia/genética , Anemia/congénito , Anemia/diagnóstico , Anemia/genética , Ascitis/congénito , Ascitis/diagnóstico , Ascitis/genética , Resultado Fatal , Femenino , Marcadores Genéticos , Hepatomegalia/congénito , Hepatomegalia/diagnóstico , Enfermedades Autoinflamatorias Hereditarias/diagnóstico , Heterocigoto , Humanos , Lactante , Linfohistiocitosis Hemofagocítica/congénito , Linfohistiocitosis Hemofagocítica/diagnóstico , Esplenomegalia/congénito , Esplenomegalia/diagnóstico , Síndrome , Trombosis/congénito , Trombosis/diagnóstico , Trombosis/genética
3.
Am J Reprod Immunol ; 70(6): 472-84, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24238108

RESUMEN

OBJECTIVE: Chlamydia trachomatis infections are a significant cause of reproductive tract pathology. Protective and pathological immune mediators must be differentiated to design a safe and effective vaccine. METHODS: Wild-type mice and mice deficient in IL-22 and IL-23 were infected intravaginally with Chlamydia muridarum, and their course of infection and oviduct pathology were compared. Local genital tract and draining lymph node immune responses were also examined in IL-23-deficient mice. RESULTS: IL-22- and IL-23-deficient mice exhibited normal susceptibility to infection and oviduct pathology. IL-23 was required for the development of a Chlamydia-specific Th17 response in the lymph nodes and for production of IL-22 and IL-17 in the genital tract. However, influx of Th1 and innate immune cells was not compromised in the absence of IL-23. CONCLUSION: IL-22 and IL-23 play either redundant or minimal roles in the pathogenesis of Chlamydia infection in the mouse model. Induction of Th17-associated cytokines by a Chlamydia vaccine should be avoided as these responses are not central to resolution of infection and have pathologic potential.


Asunto(s)
Infecciones por Chlamydia/inmunología , Chlamydia muridarum/inmunología , Interleucina-17/biosíntesis , Interleucina-23/inmunología , Interleucinas/biosíntesis , Infecciones del Sistema Genital/inmunología , Animales , Células Cultivadas , Infecciones por Chlamydia/microbiología , Infecciones por Chlamydia/patología , Femenino , Interleucina-17/inmunología , Interleucina-23/deficiencia , Interleucinas/deficiencia , Interleucinas/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Oviductos/inmunología , Oviductos/patología , Infecciones del Sistema Genital/microbiología , Infecciones del Sistema Genital/patología , Interleucina-22
5.
Infect Immun ; 80(6): 2194-203, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22431649

RESUMEN

The significant morbidities of ectopic pregnancy and infertility observed in women after Chlamydia trachomatis genital infection result from ascension of the bacteria from the endocervix to the oviduct, where an overly aggressive inflammatory response leads to chronic scarring and Fallopian tube obstruction. A vaccine to prevent chlamydia-induced disease is urgently needed. An important question for vaccine development is whether sterilizing immunity at the level of the oviduct is essential for protection because of the possibility that a chlamydial component drives a deleterious anamnestic T cell response upon oviduct reinfection. We show that mice inoculated with attenuated plasmid-cured strains of Chlamydia muridarum are protected from oviduct pathology upon challenge with wild-type C. muridarum Nigg despite induction of a response that did not prevent reinfection of the oviduct. Interestingly, repeated abbreviated infections with Nigg also elicited recall responses that protected the oviduct from pathology despite low-level reinfection of this vulnerable tissue site. Challenged mice displayed significant decreases in tissue infiltration of inflammatory leukocytes with marked reductions in frequencies of neutrophils but significant increases in frequencies of CD4 Th1 and CD8 T cells. An anamnestic antibody response was also detected. These data indicate that exposure to a live attenuated chlamydial vaccine or repeated abbreviated genital infection with virulent chlamydiae promotes anamnestic antibody and T cell responses that protect the oviduct from pathology despite a lack of sterilizing immunity at the site.


Asunto(s)
Infecciones por Chlamydia/inmunología , Chlamydia muridarum/inmunología , Enfermedades de los Genitales Femeninos/inmunología , Oviductos/patología , Animales , Vacunas Bacterianas , Infecciones por Chlamydia/microbiología , Infecciones por Chlamydia/patología , Femenino , Enfermedades de los Genitales Femeninos/microbiología , Enfermedades de los Genitales Femeninos/patología , Inflamación/metabolismo , Leucocitos/fisiología , Ratones , Ratones Endogámicos C3H , Oviductos/citología , Embarazo , Células TH1/fisiología , Factores de Tiempo , Vacunas Atenuadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...